Delays In Radiation Therapy Lead To Increased Breast Cancer Recurrence, Analysis Shows Dec 3, 2008
2, 2008) A new analysis of the National Cancer Institute's cancer registry has found that as many as one in five older women experience delayed or incomplete radiation treatment following breast-conserving surgery, and that this suboptimal care can lead to worse outcomes. Dr. Heather Taffet Gold of Weill Cornell Medical College and colleagues found that among a nationally representative sample of nearly 8,000 breast cancer registry patients aged 65 and older, almost 1,300 women experienced... (Science Daily)
Young Women Diagnosed with Early-Stage Breast Cancer More Likely to Die than Older Women Oct 16, 2008
SAN FRANCISCO, Oct. 15 /PRNewswire-USNewswire/ -- In a national study presented earlier today at the 2008 American College of Surgeons (ACS) Clinical Congress, a researcher reported that "women under 40 years of age diagnosed with Stage I breast cancer are 44 percent more likely to die than older women." According to Julie A. Margenthaler, MD, assistant professor of surgery, Washington University School of Medicine, St. Louis, MO, "These are women with similar size tumor and lymph node status.... (PR Newswire)
Many colorectal cancer survivors do not receive recommended follow-up care Sep 8, 2008
Public release date: 8-Sep-2008. Contact: David Sampson. (EurekAlert!)
Skin cancer rates grow among younger women Jul 13, 2008
$7 online stock trades. Statistics show rate of dangerous melanoma up 50 percent since 1980. (MSNBC -- Health)
Karmanos Doctors Urge Increased Screening for Previously Treated Lung Cancer Patients, Especially Young Women Jun 2, 2008
The SEER Program registries routinely collect data on patient demographics, primary tumor site, tumor morphology and stage at diagnosis, first course of treatment, and follow-up for vital status. The SEER Program is the only comprehensive source of population-based information in the United States that includes stage of cancer at the time of diagnosis and patient survival data. (PR Newswire)
Most Lethal Melanomas Are On Scalp And Neck Apr 23, 2008
22, 2008) People with scalp or neck melanomas die at nearly twice the rate of people with melanoma elsewhere on the body, including the face or ears, researchers at the University of North Carolina at Chapel Hill have found. The analysis of 51,704 melanoma cases in the U.S. confirms that survival rates differ depending on where skin cancer first appears. (Science Daily)
Testicular Cancer Gauge Often Not Used Mar 21, 2008
20, 2008) A standard part of testicular cancer care isn't used in more than half of all patients who have the condition, researchers at the University of Michigan Comprehensive Cancer Center have found. Serum-based tumor markers, which are one indicator of the presence of cancer cells, are helpful in several aspects of the care of patients with testis cancer, including diagnosis, prognostication and surveillance for disease recurrence following treatment. (Science Daily)
Kidney cancer surgery often determined by surgeons' practice style, not medical factors Mar 10, 2008
Public release date: 10-Mar-2008. A new study reveals that the type of surgery a patient with kidney cancer receives depends more on the surgeons preference than on the patients tumor size, demographic characteristics, or general medical health. (EurekAlert!)
Breast Cancer Gene Carriers Need Dual Screening Feb 28, 2008
Tuesday, February 26, 2008. By Anthony J. Brown, MD. (MEDLINEplus)
New Model Predicts Breast Cancer Risk In African-American Women Dec 2, 2007
1, 2007) Researchers have developed a new risk prediction model that more accurately estimates the breast cancer risk of African American women, according to a new study. The Breast Cancer Risk Assessment Tool, also known as the Gail model, is widely used for estimating breast cancer risk and for determining which women are eligible for breast cancer prevention trials. (Science Daily)
Surgery, Radiation Gives Early Survival Advantage In Bile Duct Cancer Nov 1, 2007
31, 2007) Oregon Health & Science University researchers are reporting the discovery of an early survival advantage when a combination of surgery and radiation therapy is used for patients with a rare but deadly bile duct cancer. "Surgery and radiotherapy shows an early response benefit. It shows that the addition of radiation is potentially reasonable for the first-line treatment," said Clifton David Fuller, M.D., Ph. (Science Daily)
OHSU researchers: Surgery, radiation gives early survival advantage in bile duct cancer Oct 29, 2007
Public release date: 28-Oct-2007. Contact: Christine Decker. (EurekAlert!)
Filtered Cigarettes Blamed for Huge Rise in Type of Lung Cancer Sep 8, 2007
Adenocarcinoma, once rare, now the leading lung cancer killer, study says. Thursday, September 6, 2007. (MEDLINEplus)
Rates of Lymphoma Increase Over 30 Years Jul 20, 2007
Friday, July 20, 2007 Current User :: Guest. The rates of the disease vary by race, sex and geographic area. (Kansas City infoZine)
Cutaneous T-cell Lymphoma On The Rise, Research Shows Jul 18, 2007
Cutaneous T-cell lymphoma, a rare and mysterious cancer, is on the rise, according to the first nationwide study of the disease in a decade. The study, conducted by researchers at the Providence VA Medical Center and The Warren Alpert Medical School of Brown University, found that 4,783 new cases of cutaneous T-cell lymphoma were diagnosed between 1973 and 2002, the period under review. (Science Daily)
Disparities Persist in Cancer Care Jun 5, 2007
Studies show racial, socioeconomic gaps continue with breast, childhood cancers. Sunday, June 3, 2007. (MEDLINEplus)
First Degree Relatives Of Patients With Lung Cancer Have Increased Cancer Risk May 11, 2007
A new study reveals that first-degree relatives of patients with early-onset lung cancer are at an increased risk of developing other types of cancer. Furthermore, the risk is largely affected by race. (Science Daily)
Growth Factors Given With Chemotherapy Associated With Increased Risk Of Blood Diseases Feb 8, 2007
Women with breast cancer who receive compounds that stimulate white blood cell production to help their bodies better tolerate chemotherapy are at an increased risk of developing a type of leukemia or a condition called myelodysplastic syndrome, according to a new study in the February 7 Journal of the National Cancer Institute. The authors note that the absolute risk of the conditions is very small, but that risk should still be taken into consideration when making treatment decisions. (Science Daily)
